Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2. Singh RK, Soliman A, Guaitoli G, Stormer E, et al. Proc Natl Acad Sci U S A 2022;119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singh RK, Soliman A, Guaitoli G, Stormer E, et al. Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2. Proc Natl Acad Sci U S A 2022;119.
PMID: 35217606